Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Codeine phosphate hemihydrate
Mercury Pharmaceuticals (Ireland) Ltd
R05DA; R05DA04
Codeine phosphate hemihydrate
30 milligram(s)
Tablet
Product subject to prescription which may not be renewed (A)
Opium alkaloids and derivatives; codeine
Not marketed
1978-04-01
1 PACKAGE LEAFLET: INFORMATION FOR THE USER CODANT 30MG TABLETS codeine phosphate hemihydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Codant is and what it is used for 2. What you need to know before you take Codant 3. How to take Codant 4. Possible side effects 5. How to store Codant 6. Contents of the pack and other information 1. WHAT CODANT IS AND WHAT IT IS USED FOR Codant can be used in children over 12 years of age for the short-term relief of moderate pain that is not relieved by other painkillers such as paracetamol or ibuprofen alone. This product contains codeine. Codeine belongs to a group of medicines called opioid analgesics which act to relieve pain. It can also be used for relief of non-productive (dry) cough in adults . It can be used on its own or in combination with other pain killers such as paracetamol _ _ 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CODANT Do not take for longer than directed by your prescriber. Taking codeine regularly for a long time can lead to addiction, which might cause you to feel restless and irritable when you stop the tablets. Taking a painkiller for headaches too often or for too long can make them worse. Do not use Codant for pain relief in children and adolescents (0-18 years of age) after removal of their tonsils or adenoids as Codant may cause obstructive sleep apnoea syndrome (sleep disruption due to respiratory pauses). DO NOT TAKE CODANT • if you are allergic to codeine phosphate hemihydrate or any of the other ingredients o Read the complete document
Health Products Regulatory Authority 01 February 2022 CRN00CK7N Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Codant 30 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Codeine Phosphate Hemihydrate 30 mg (equivalent to 23.4 mg Codeine). Excipient(s) with known effect Also contains 43 mg of lactose monohydrate (equivalent to 40.9 mg lactose). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets. White, circular biconvex tablets of 5.5mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1) Management of mild to moderate pain. Codeine is indicated in patients older than 12 years of age for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen alone. 2) As an anti-tussive for non-productive cough. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ The usual dose is 30mg (one tablet), repeated 6 hourly as required. Codeine should be used at the lowest effective dose for the shortest period of time. This dose may be taken, up to 4 times a day at intervals of not less than 6 hours. Maximum daily dose should not exceed 240 mg. The duration of treatment should be limited to 3 days and if no effective pain relief is achieved the patients/carers should be advised to seek the views of a physician. _Elderly: _ A reduced dosage may be necessary. _Paediatric population:_ Children aged 12 years to 18 years: "The recommended codeine dose for children 12 years and older should be 30 to 60 mg every 6 hours when necessary up to a maximum dose of 240 mg daily. The dose is based on the body weight (0.5-1mg/kg)." Children aged less than 12 years: Health Products Regulatory Authority 01 February 2022 CRN00CK7N Page 2 of 7 "Codeine should not be used in children below the age of 12 years because of the risk of opioid toxicity due to the variable and unpredictable metabolism of codeine to morphine (see sections 4.3 and 4.4). Dosage needs to be adjusted according to the s Read the complete document